Employees of the pharmaceutical giant Bristol Myers Squibb ride bicycles in a relay from Oregon to New Jersey every year as a fundraiser for The V Foundation which funds cancer research. They stopped in Kansas City Thursday.
The University of Kansas Cancer Center has joined with trial tech provider Complion to develop a shared investigator platform for use in a range of studies.
Share this article
Share this article
CLEVELAND, May 20, 2021 /PRNewswire/ Complion has developed a best-in-breed Shared Investigator Platform (SIP) integration in partnership with The University of Kansas Cancer Center (KU Cancer Center), which will be readily available across all Complion sites, including the largest base of more than 14,000 clinical trials.
This integration will provide a single standard method for KU Cancer Center to work across the numerous major sponsors it works with on clinical research studies. The integration is the final step necessary to enable KU Cancer Center to fully adopt SIP and achieve the benefits of faster feasibility as well as securing additional studies by eliminating objections from specific sponsors while becoming favorable for other sponsors seeking sites for their studies.
Hoefer Welker designs KU Cancer Center s new proton treatment center - Kansas City Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.